Takeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Down 26.5% in April

Takeda Pharmaceutical Company Limited (NYSE:TAK) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 5,970,000 shares, a drop of 26.5% from the March 31st total of 8,120,000 shares. Currently, 0.2% of the company’s shares are short sold. Based on an average daily volume of 1,850,000 shares, the short-interest ratio is presently 3.2 days.

Institutional Trading of Takeda Pharmaceutical

A number of institutional investors have recently bought and sold shares of the company. NBC Securities Inc. lifted its stake in shares of Takeda Pharmaceutical by 1.8% in the 1st quarter. NBC Securities Inc. now owns 43,539 shares of the company’s stock valued at $614,000 after purchasing an additional 765 shares during the period. Sage Rhino Capital LLC increased its holdings in Takeda Pharmaceutical by 7.6% in the third quarter. Sage Rhino Capital LLC now owns 11,751 shares of the company’s stock worth $182,000 after purchasing an additional 831 shares in the last quarter. Legacy Wealth Asset Management LLC lifted its stake in Takeda Pharmaceutical by 0.7% in the third quarter. Legacy Wealth Asset Management LLC now owns 124,967 shares of the company’s stock valued at $1,933,000 after buying an additional 851 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Takeda Pharmaceutical by 0.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 130,904 shares of the company’s stock worth $1,818,000 after buying an additional 857 shares in the last quarter. Finally, Vestmark Advisory Solutions Inc. grew its position in shares of Takeda Pharmaceutical by 1.4% during the 3rd quarter. Vestmark Advisory Solutions Inc. now owns 63,630 shares of the company’s stock worth $984,000 after buying an additional 870 shares during the period. Institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Trading Down 0.3 %

Shares of TAK traded down $0.04 during mid-day trading on Friday, reaching $13.03. 1,213,476 shares of the company were exchanged, compared to its average volume of 1,688,482. The business has a 50 day simple moving average of $14.06 and a two-hundred day simple moving average of $14.20. Takeda Pharmaceutical has a 52 week low of $13.01 and a 52 week high of $17.11. The stock has a market capitalization of $41.24 billion, a PE ratio of 19.74, a PEG ratio of 2.98 and a beta of 0.53. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.55 and a current ratio of 1.06.

Takeda Pharmaceutical (NYSE:TAK) last issued its quarterly earnings results on Thursday, February 1st. The company reported $0.51 earnings per share (EPS) for the quarter. Takeda Pharmaceutical had a net margin of 6.90% and a return on equity of 12.57%. The firm had revenue of $7.52 billion for the quarter. On average, analysts predict that Takeda Pharmaceutical will post 1.5 earnings per share for the current fiscal year.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.